Clinical Trial Update: Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating MR imaging using hyperpolarized 13C-pyruvate with or without 13C,15N-urea in prostate cancer patients, and the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Hyperpolarized 13C,15N-Urea (13C,15N-urea)
• Hyperpolarized 13C-pyruvate (hyperpolarized 13C-labeled pyruvate)

Snippet

Sponsor: Robert Bok, MD, PhD | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING